Summary
PolyPid Ltd (PolyPid) is a clinical stage pharmaceutical company that develops, manufactures and commercialize drugs for extended release and local delivery. The company develops its products using PLEX (Polymer-Lipid Encapsulation MatriX) platform, which helps in products. PolyPid’s pipeline product candidates include BonyPid-1000 and BonyPid-500, both of which are bone graft materials for filling bone voids and defects, and D-Plex, an antibiotic drug reservoir, which can be implanted during surgical procedures for prolonged infection management over several weeks and minimizes the potential side effects and lowers the cost of treatment significantly, localized medication solution is essential in many treatment regimens. The company has partnerships with various organizations such as MIS Dental Implants Ltd, Rimonim and BALI to develop novel products. PolyPid is headquartered in Petach Tikva, Israel.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company PolyPid Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
- PolyPid Ltd Company Overview
- PolyPid Ltd Company Snapshot
- PolyPid Ltd Pipeline Products and Ongoing Clinical Trials Overview
- PolyPid Ltd – Pipeline Analysis Overview
- PolyPid Ltd - Key Facts
- PolyPid Ltd - Major Products and Services
- PolyPid Ltd Pipeline Products by Development Stage
- PolyPid Ltd Ongoing Clinical Trials by Trial Status
- PolyPid Ltd Pipeline Products Overview
- BonyPid-1000
- BonyPid-1000 Product Overview
- BonyPid-1000 Clinical Trial
- BonyPid-500
- BonyPid-500 Product Overview
- BonyPid-500 Clinical Trial
- D-PLEX
- D-PLEX Product Overview
- D-PLEX Clinical Trial
- PolyPid Ltd - Key Competitors
- PolyPid Ltd - Key Employees
- PolyPid Ltd - Key Employee Biographies
- PolyPid Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- PolyPid Ltd, Recent Developments
- Dec 21, 2017: PolyPid Appoints Jacob Harel as Chairman of the Board of Directors
- Aug 16, 2017: PolyPid Completes Enrollment in Phase Ib/II Study of D-PLEX in Post-Cardiac Surgery Sternal Infection
- Mar 09, 2017: PolyPid Announces Positive Interim Data from Company's Confirmatory Clinical Trial for BonyPid-1000 Antibiotic Eluting Bone Substitute
- Mar 08, 2017: PolyPid Announces Receipt of Qualified Infectious Disease Product Designation from FDA for D-PLEX in Post-Cardiac Surgery Sternal Infection
- Dec 02, 2015: PolyPid Announces First Patient Enrolled in Confirmatory Clinical Trial, Evaluating Performance and Safety of BonyPid-1000, an Antibiotic Eluting Bone Void Filler
- Nov 19, 2015: PolyPid Announces Issuance of New U.S. Patent for Doxycycline Sustained Release Compositions
- Jul 07, 2014: PolyPid Announces US Patent Allowance for Sustained Release of Nucleic Acid Matrix Compositions
- Jun 18, 2014: PolyPid Wins First Prize at Biomed Startup Competition
- Dec 10, 2012: PolyPid Announces Positive Preliminary Results Of Clinical Trial With BonyPid
- Apr 23, 2012: PolyPid Joins Rimonim Consortium to Develop Delivery System for RNA-based Drugs
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- PolyPid Ltd Pipeline Products and Ongoing Clinical Trials Overview
- PolyPid Ltd Pipeline Products by Equipment Type
- PolyPid Ltd Pipeline Products by Indication
- PolyPid Ltd Ongoing Clinical Trials by Trial Status
- PolyPid Ltd, Key Facts
- PolyPid Ltd, Major Products and Services
- PolyPid Ltd Number of Pipeline Products by Development Stage
- PolyPid Ltd Pipeline Products Summary by Development Stage
- PolyPid Ltd Ongoing Clinical Trials by Trial Status
- PolyPid Ltd Ongoing Clinical Trials Summary
- BonyPid-1000 - Product Status
- BonyPid-1000 - Product Description
- BonyPid-1000 - Safety and Performance of BonyPid-1000 in the Treatment of Gustilo IIIA and IIIB Tibial Open Fractures
- BonyPid-500 - Product Status
- BonyPid-500 - Product Description
- BonyPid-500 - PolyPid, Ltd. Pilot Study of the BonyPid-500 Bone Graft Substitute
- D-PLEX - Product Status
- D-PLEX - Product Description
- D-PLEX - A Phase Ib/II Prospective, Multicenter, Two Part Study; Part 1 - Open Label, Single Arm and Part 2 Randomized, Single-blinded (Study to Assess Safety and Efficacy of D-PLEX Concomitantly with Standard of Care Versus Standard of Care Alone in the Prevention of Primary Sternal Infection Post Cardiac Surgery
- PolyPid Ltd, Key Employees
- PolyPid Ltd, Key Employee Biographies
- Glossary
- List of Figures
- PolyPid Ltd Pipeline Products by Equipment Type
- PolyPid Ltd Pipeline Products by Development Stage
- PolyPid Ltd Ongoing Clinical Trials by Trial Status